Blood Pressure Drugs and Heart Failure
Journal: Annals of Internal Medicine (2002)

Summaries for Patients3 September 2002Blood Pressure Drugs and Heart FailureSearch for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-137-5_Part_1-200209030-00002 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail What is the problem and what is known about it so far?High blood pressure (hypertension) is a chronic condition that damages blood vessels and body organs. It increases the risk for heart attacks, heart failure, strokes, and kidney failure. Although the many types of drugs used to treat hypertension may reduce blood pressure by a similar amount, their ability to prevent complications of hypertension may vary. Also, different drugs cause different side effects.Researchers showed that heart failure occurred more often in hypertensive patients taking an α-blocker (doxazosin) than a diuretic (chlorthalidone). However, the α-blocker reduced blood pressure slightly ... Author, Article, and Disclosure InformationAffiliations: The summary below is from the full report titled “Relationship of Antihypertensive Treatment Regimens and Change in Blood Pressure to Risk for Heart Failure in Hypertensive Patients Randomly Assigned to Doxazosin or Chlorthalidone: Further Analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial.” It is in the 3 September 2002 issue of Annals of Internal Medicine (volume 137, pages 313-320). The authors are BR Davis, JA Cutler, CD Furberg, JT Wright Jr., MA Farber, JV Felicetta, and JD Stokes, for the ALLHAT Collaborative Research Group.Summaries for Patients are a service provided by Annals to help patients better understand the complicated and often mystifying language of modern medicine.Summaries for Patients are presented for informational purposes only. These summaries are not a substitute for advice from your own medical provider. If you have questions about this material, or need medical advice about your own health or situation, please contact your physician. The summaries may be reproduced for not-for-profit educational purposes only. Any other uses must be approved by the American College of Physicians-American Society of Internal Medicine. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoRelationship of Antihypertensive Treatment Regimens and Change in Blood Pressure to Risk for Heart Failure in Hypertensive Patients Randomly Assigned to Doxazosin or Chlorthalidone: Further Analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial Barry R. Davis , Jeffrey A. Cutler , Curt D. Furberg , Jackson T. Wright Jr. , Michael A. Farber , James V. Felicetta , John D. Stokes , and Relationship of Antihypertensive Treatment Regimens and Change in Blood Pressure to Risk for Heart Failure in Hypertensive Patients Randomly Assigned to Doxazosin or Chlorthalidone: Further Analyses from the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial Barry R. Davis , Jeffrey A. Cutler , Curt D. Furberg , Jackson T. Wright Jr. , Michael A. Farber , James V. Felicetta , John D. Stokes , and Metrics 3 September 2002Volume 137, Issue 5_Part_1Page: I-38KeywordsBlood pressureCardiovascular therapyDiureticsDrug regulationDrugsHeart failureHypertensionMyocardial infarctionPrimary hypertensionStroke ePublished: 3 September 2002 Issue Published: 3 September 2002 Copyright & PermissionsCopyright © 2002 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...